ArticleInternational medical case reports journal2026
Pharyngeal-Cervical-Brachial Variant of Guillain-Barré Syndrome with Neck and Shoulder Pain as the Initial Symptom: A Case Report.
Article in International medical case reports journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Guillain-Barré syndrome (GBS) is a type of immune-mediated acute self-limiting peripheral neuropathy. Pharyngeal-cervical brachial (PCB) is a rare variant of GBS spectrum disorder It carries a risk of misdiagnosis. To improve awareness of rare GBS variants is of importance for early recognition. Case Report: A 58-year-old woman, who initially presented with shoulder and neck pain, subsequently developed rapidly progressive limb weakness, dysphagia, and respiratory compromise and underwent a neurological evaluation including brain and cervical MRI, cerebrospinal fluid analysis, ganglioside antibody testing, and electromyography (EMG). She received supportive care and treatment with intravenous immunoglobulin (IVIG). Initial MRI findings were unremarkable. CSF analysis revealed elevated protein with mild pleocytosis, and EMG demonstrated acute motor-sensory axonal and demyelinating polyneuropathy with slowed nerve conduction. Following IVIG therapy, the patient's respiratory function stabilized, motor strength gradually recovered, and she resumed walking after 2 months. One-year follow-up indicated full clinical recovery and improved EMG findings. Conclusion: This case underscores the necessity of recognising and addressing rare Guillain-Barré variants with similar presentations in clinical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.